BioCentury | Jul 31, 2006
Company News

Albany Molecular Research chemistry news

...ComGenex Inc. (Budapest, Hungary) changed its name to AMRI Hungary. In February, AMRI acquired ComGenex for...
BioCentury | Mar 6, 2006
Company News

Albany Molecular Research, ComGenex deal

...AMRI completed its previously announced acquisition of ComGenex for $11 million in cash (see BioCentury, Feb...
...$11 million in cash (see BioCentury, Feb. 6). Albany Molecular Research Inc. (AMRI), Albany, N.Y. ComGenex Inc....
BioCentury | Feb 6, 2006
Company News

Albany Molecular Research, ComGenex deal

...AMRI will acquire ComGenex for $11 million in cash. ComGenex, a chemistry services company, had $8.5...
...The deal is expected to close this quarter. Albany Molecular Research Inc. (AMRI), Albany, N.Y. ComGenex Inc....
BioCentury | Mar 7, 2005
Company News

ComGenex, Bayer deal

...under which ComGenex is providing BAYG's Bayer Healthcare unit with chemistry services and compound libraries. ComGenex Inc....
BioCentury | Feb 7, 2005
Company News

Aeterna Zentaris, ComGenex deal

...PI3 kinase inhibitors for cancer discovered through a joint discovery program with ComGenex. In 2002, ComGenex...
...2002). Last November, the partners amended the deal to give Echelon an option to acquire ComGenex's...
...in stock (see BioCentury, Jan. 10, 2004). Aeterna Zentaris Inc. (TSE:AEZ; AEZS), Quebec City, Quebec ComGenex Inc....
BioCentury | Feb 1, 2005
Company News

ComGenex, Echelon cancer deal

...and market certain PI3 kinase inhibitor cancer candidates discovered through a joint discovery program with ComGenex...
...Last November, the partners amended the deal to give Echelon an option to acquire ComGenex's...
BioCentury | Nov 1, 2004
Company News

ComGenex, Echelon Biosciences Inc. deal

...and inflammatory diseases (see BioCentury, Feb. 4, 2002). Echelon now has the right to acquire ComGenex's...
...from ComGenex's compound libraries that have shown efficacy in xenograft animal models against ovarian cancer. ComGenex Inc....
BioCentury | Jan 19, 2004
Company News

ComGenex, AstraZeneca deal

...optimal conditions to fold the complex proteins for full functionality. AZN will own resulting proteins. ComGenex Inc....
BioCentury | Dec 8, 2003
Company News

ComGenex, Bayer deal

...sixth year their combinatorial supply deal under which ComGenex is providing compound libraries to BAYG. ComGenex Inc....
BioCentury | Apr 7, 2003
Company News

ComGenex management update

ComGenex Inc. , Budapest, Hungary Business: Chemistry, ADMET Hired: Klaus Frobel as EVP of medicinal chemistry and discovery technologies, formerly global head of medicinal chemistry at Bayer AG WIR Staff...
Items per page:
1 - 10 of 25
BioCentury | Jul 31, 2006
Company News

Albany Molecular Research chemistry news

...ComGenex Inc. (Budapest, Hungary) changed its name to AMRI Hungary. In February, AMRI acquired ComGenex for...
BioCentury | Mar 6, 2006
Company News

Albany Molecular Research, ComGenex deal

...AMRI completed its previously announced acquisition of ComGenex for $11 million in cash (see BioCentury, Feb...
...$11 million in cash (see BioCentury, Feb. 6). Albany Molecular Research Inc. (AMRI), Albany, N.Y. ComGenex Inc....
BioCentury | Feb 6, 2006
Company News

Albany Molecular Research, ComGenex deal

...AMRI will acquire ComGenex for $11 million in cash. ComGenex, a chemistry services company, had $8.5...
...The deal is expected to close this quarter. Albany Molecular Research Inc. (AMRI), Albany, N.Y. ComGenex Inc....
BioCentury | Mar 7, 2005
Company News

ComGenex, Bayer deal

...under which ComGenex is providing BAYG's Bayer Healthcare unit with chemistry services and compound libraries. ComGenex Inc....
BioCentury | Feb 7, 2005
Company News

Aeterna Zentaris, ComGenex deal

...PI3 kinase inhibitors for cancer discovered through a joint discovery program with ComGenex. In 2002, ComGenex...
...2002). Last November, the partners amended the deal to give Echelon an option to acquire ComGenex's...
...in stock (see BioCentury, Jan. 10, 2004). Aeterna Zentaris Inc. (TSE:AEZ; AEZS), Quebec City, Quebec ComGenex Inc....
BioCentury | Feb 1, 2005
Company News

ComGenex, Echelon cancer deal

...and market certain PI3 kinase inhibitor cancer candidates discovered through a joint discovery program with ComGenex...
...Last November, the partners amended the deal to give Echelon an option to acquire ComGenex's...
BioCentury | Nov 1, 2004
Company News

ComGenex, Echelon Biosciences Inc. deal

...and inflammatory diseases (see BioCentury, Feb. 4, 2002). Echelon now has the right to acquire ComGenex's...
...from ComGenex's compound libraries that have shown efficacy in xenograft animal models against ovarian cancer. ComGenex Inc....
BioCentury | Jan 19, 2004
Company News

ComGenex, AstraZeneca deal

...optimal conditions to fold the complex proteins for full functionality. AZN will own resulting proteins. ComGenex Inc....
BioCentury | Dec 8, 2003
Company News

ComGenex, Bayer deal

...sixth year their combinatorial supply deal under which ComGenex is providing compound libraries to BAYG. ComGenex Inc....
BioCentury | Apr 7, 2003
Company News

ComGenex management update

ComGenex Inc. , Budapest, Hungary Business: Chemistry, ADMET Hired: Klaus Frobel as EVP of medicinal chemistry and discovery technologies, formerly global head of medicinal chemistry at Bayer AG WIR Staff...
Items per page:
1 - 10 of 25